AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
16:08
Gigel Știrbu, PNL vice president, criticizes the opulence displayed at the baptism of Alfred Simonis’s son: “Caviar socialists”
15:47
Police found the three missing brothers from Sălaj after a large-scale search operation
15:30
Violent protests in Europe have also spread to Switzerland
15:09
Radu Miruță: “Dominic Fritz remains the USR leader until 2029”
14:54
Andrés Ritter takes over leadership of the European Public Prosecutor’s Office; Kövesi warns of risks to the institution’s independence
See more news